Clinical trial
Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals
NCT00249483 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00249483 |
|---|---|
| Title | Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals |
| Official title | Placebo-Controlled Venlafaxine Treatment for Depressed Cocaine Abusers |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Venlafaxine, Placebo |
| Enrollment | 150 |
| Start date | Oct 1, 1999 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Nov 7, 2005 |
| Last update posted | Jul 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: